LY-255582

N/A

Report date: 2023/10/11 09:09:54
NME

Base Information

Drug NameLY-255582
Drug Alias NameLY-255582
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOpioid receptors antagonists
TargetsOpioid receptors
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksN/A